| | [Table 4.1] |
|---|
| | Note | 2010 | 2011 |
| | | € million | € million |
| Net sales | [7] | 35,088 | 36,528 |
| Cost of goods sold | | (17,103) | (17,975) |
| Gross profit | | 17,985 | 18,553 |
| | | | |
| Selling expenses | [8] | (8,803) | (8,958) |
| Research and development expenses | [9] | (3,053) | (2,932) |
| General administration expenses | | (1,647) | (1,713) |
| Other operating income | [10] | 714 | 859 |
| Other operating expenses | [11] | (2,466) | (1,660) |
| Operating result (EBIT) | | 2,730 | 4,149 |
| | | | |
| Equity-method loss | [13.1] | (56) | (45) |
| Non-operating income | | 384 | 586 |
| Non-operating expenses | | (1,337) | (1,327) |
| Non-operating result | [13] | (1,009) | (786) |
| | | | |
| Income before income taxes | | 1,721 | 3,363 |
| | | | |
| Income taxes | [14] | (411) | (891) |
| | | | |
| Income after taxes | | 1,310 | 2,472 |
| of which attributable to non-controlling interest | [15] | 9 | 2 |
of which attributable to Bayer AG stockholders
(net income) | | 1,301 | 2,470 |
| | | | |
| | | € | € |
| Earnings per share | [16] | | |
| Basic | | 1.57 | 2.99 |
| Diluted | | 1.57 | 2.99 |